Atorvastatin IR Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Atorvastatin IR Pellets – Pharmaceutical-Grade Immediate-Release Pellets

Atorvastatin IR Pellets are pharmaceutical-grade immediate-release multiparticulate pellets containing Atorvastatin Calcium as the active ingredient. Atorvastatin Calcium has the anhydrous CAS Number 134523-03-8, molecular formula C₆₆H₆₈CaF₂N₄O₁₀, and molecular weight 1155.36 g/mol. The USP specification for Atorvastatin Calcium requires 98.0–102.0% on an anhydrous and solvent-free basis.

The immediate-release pellet format is designed to provide rapid availability of the active ingredient after administration. Atorvastatin can be incorporated into multiparticulate pellets using suitable pelletization technology, with the formulation controlling active loading, pellet size, mechanical properties, assay and dissolution characteristics.

Commercially documented Atorvastatin IR Pellets include 10% and 20% w/w strengths. Other commercial portfolios also report 7.5%, 15% and 20% strengths.

For the SDP website, 10% and 20% w/w are the commercially documented strengths most directly supported by the reviewed pellet portfolios. Publish them as SDP strengths only if they match the current SDP product specification or COA.

Key Features

  • Pharmaceutical-grade Atorvastatin IR Pellets
  • Active ingredient: Atorvastatin Calcium
  • Immediate-release multiparticulate format
  • Suitable for capsule-filling applications
  • Suitable for oral multiparticulate formulations
  • Product-specific active loading
  • Controlled pellet size and flow characteristics
  • Suitable for formulation development
  • Suitable for bulk pharmaceutical manufacturing
  • Product-specific assay and dissolution specifications

Applications

Immediate-Release Oral Formulations

Atorvastatin IR Pellets are designed for immediate-release oral formulations requiring rapid release of the active ingredient.

Capsule Filling

The multiparticulate format is suitable for incorporation into capsule dosage forms according to the required strength and formulation specification.

Multiparticulate Formulation Development

Atorvastatin pellets provide a flexible intermediate for development of oral multiparticulate dosage forms.

Pharmaceutical Manufacturing

The pellets can be used as a formulation intermediate for pharmaceutical manufacturers developing immediate-release products.

Bulk Pharmaceutical Supply

Atorvastatin IR Pellets can be supplied in bulk according to active loading, pellet-size distribution and approved quality specifications.

Why Atorvastatin IR Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
  • Immediate-Release Format – Designed for rapid release of Atorvastatin Calcium.
  • Product-Specific Active Loading – Available loading is controlled according to the applicable specification.
  • Multiparticulate Format – Suitable for capsule filling and oral multiparticulate formulations.
  • Controlled Pellet Characteristics – Pellet size, assay, moisture and dissolution can be controlled according to the approved specification.
  • Formulation Flexibility – Suitable for immediate-release formulation development.
  • Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturers requiring bulk pellet intermediates.
  • Atorvastatin Pellet Supplier Support – Product and supply parameters can be aligned with formulation requirements.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp